
Auxly Cannabis Group Inc
TSX:XLY

Auxly Cannabis Group Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.03
0.17
|
Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Auxly Cannabis Group Inc hold over its rivals?
What risks and challenges
does Auxly Cannabis Group Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Auxly Cannabis Group Inc.
Provide an overview of the primary business activities
of Auxly Cannabis Group Inc.
What unique competitive advantages
does Auxly Cannabis Group Inc hold over its rivals?
What risks and challenges
does Auxly Cannabis Group Inc face in the near future?
Summarize the latest earnings call
of Auxly Cannabis Group Inc.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Auxly Cannabis Group Inc.
Provide P/S
for Auxly Cannabis Group Inc.
Provide P/E
for Auxly Cannabis Group Inc.
Provide P/OCF
for Auxly Cannabis Group Inc.
Provide P/FCFE
for Auxly Cannabis Group Inc.
Provide P/B
for Auxly Cannabis Group Inc.
Provide EV/S
for Auxly Cannabis Group Inc.
Provide EV/GP
for Auxly Cannabis Group Inc.
Provide EV/EBITDA
for Auxly Cannabis Group Inc.
Provide EV/EBIT
for Auxly Cannabis Group Inc.
Provide EV/OCF
for Auxly Cannabis Group Inc.
Provide EV/FCFF
for Auxly Cannabis Group Inc.
Provide EV/IC
for Auxly Cannabis Group Inc.
Show me price targets
for Auxly Cannabis Group Inc made by professional analysts.
What are the Revenue projections
for Auxly Cannabis Group Inc?
How accurate were the past Revenue estimates
for Auxly Cannabis Group Inc?
What are the Net Income projections
for Auxly Cannabis Group Inc?
How accurate were the past Net Income estimates
for Auxly Cannabis Group Inc?
What are the EPS projections
for Auxly Cannabis Group Inc?
How accurate were the past EPS estimates
for Auxly Cannabis Group Inc?
What are the EBIT projections
for Auxly Cannabis Group Inc?
How accurate were the past EBIT estimates
for Auxly Cannabis Group Inc?
Compare the revenue forecasts
for Auxly Cannabis Group Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Auxly Cannabis Group Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Auxly Cannabis Group Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Auxly Cannabis Group Inc compared to its peers.
Compare the P/E ratios
of Auxly Cannabis Group Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Auxly Cannabis Group Inc with its peers.
Analyze the financial leverage
of Auxly Cannabis Group Inc compared to its main competitors.
Show all profitability ratios
for Auxly Cannabis Group Inc.
Provide ROE
for Auxly Cannabis Group Inc.
Provide ROA
for Auxly Cannabis Group Inc.
Provide ROIC
for Auxly Cannabis Group Inc.
Provide ROCE
for Auxly Cannabis Group Inc.
Provide Gross Margin
for Auxly Cannabis Group Inc.
Provide Operating Margin
for Auxly Cannabis Group Inc.
Provide Net Margin
for Auxly Cannabis Group Inc.
Provide FCF Margin
for Auxly Cannabis Group Inc.
Show all solvency ratios
for Auxly Cannabis Group Inc.
Provide D/E Ratio
for Auxly Cannabis Group Inc.
Provide D/A Ratio
for Auxly Cannabis Group Inc.
Provide Interest Coverage Ratio
for Auxly Cannabis Group Inc.
Provide Altman Z-Score Ratio
for Auxly Cannabis Group Inc.
Provide Quick Ratio
for Auxly Cannabis Group Inc.
Provide Current Ratio
for Auxly Cannabis Group Inc.
Provide Cash Ratio
for Auxly Cannabis Group Inc.
What is the historical Revenue growth
over the last 5 years for Auxly Cannabis Group Inc?
What is the historical Net Income growth
over the last 5 years for Auxly Cannabis Group Inc?
What is the current Free Cash Flow
of Auxly Cannabis Group Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Auxly Cannabis Group Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CA |
![]() |
Auxly Cannabis Group Inc
TSX:XLY
|
190.7m CAD | -21.8 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
722.3B USD | 35 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
395.4B USD | 13.3 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK | 12.1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
201.9B CHF | 9.2 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
177.3B CHF | 9.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
158.5B GBP | 130.5 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
199.6B USD | 8.5 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.8B USD | 292.4 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
137.9B USD | 7.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
CA |
![]() |
Auxly Cannabis Group Inc
TSX:XLY
|
Average EV/EBITDA:
436.5
|
N/A | N/A | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
35
|
30%
|
1.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
13.3
|
7%
|
1.9 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
12.1
|
13%
|
0.9 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
9.2
|
5%
|
1.8 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
9.8
|
5%
|
2 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
130.5
|
10%
|
13.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
8.5
|
8%
|
1.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
292.4
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
7.5
|
2%
|
3.8 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.